This report and position paper from the Royal Society of Victoria (RSV) addresses the conservation and recovery of Australia’s unique biodiversity, particularly in the State of Victoria. It summarises the current state of reviews, responses and policies in Victoria in the broader Australian and global context, with recommendations for action.
A senior practicing rheumatologist and clinical epidemiologist, Professor Rachelle Buchbinder conducts a broad range of multidisciplinary research projects relating to the treatment of arthritis and musculoskeletal conditions, as well as improving communication with patients and general health literacy. She has made outstanding contributions to her field through consistent excellence.
Our Society’s role as a convenor of Victoria’s science community must be reinvigorated and extended to include sectors and knowledge systems beyond academia. This way, we connect Victorians everywhere with expertise that can enable effective decision making – informed, localised responses to issues both global and regional. We are re-examining and refocusing our strategy, structure and scope of activities.
Australia has a vibrant medical technology and pharmaceutical (MTP) sector, recognised globally for its excellence and innovation. With nearly 1,300 companies and an exceptionally skilled workforce of 68,000 across industry and research, the MTP sector is a major contributor to the Australian economy. Dr Rebecca Tunstall from MTPConnect leads collaborative teams to drive connectivity, innovation and productivity in the sector.